Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Iveson

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|June 12, 2003
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancerA Saini, A R Norman, D Cunningham, et al.
The Veterinary Record|May 14, 2014
Presence of digital dermatitis treponemes on cattle and sheep hoof trimming equipmentL E Sullivan, R W Blowey, S D Carter, et al.
British Journal of Cancer|June 2, 2005
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECFK Sumpter, C Harper-Wynne, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerI Chau, A R Norman, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2010
A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trialB Sirohi, R A'Hern, G Coombes, et al.
Lancet (London, England)|April 1, 2000
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialJ Y Douillard, D Cunningham, A D Roth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?A Sobrero, A Grothey, T Iveson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancerD L Clarke-Pearson, L Van Le, T Iveson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancerS Rao, D Cunningham, A de Gramont, et al.
British Journal of Cancer|August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 StudyJ W Valle, H Wasan, P Johnson, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|June 12, 2003
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancerA Saini, A R Norman, D Cunningham, et al.
The Veterinary Record|May 14, 2014
Presence of digital dermatitis treponemes on cattle and sheep hoof trimming equipmentL E Sullivan, R W Blowey, S D Carter, et al.
British Journal of Cancer|June 2, 2005
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECFK Sumpter, C Harper-Wynne, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerI Chau, A R Norman, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2010
A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trialB Sirohi, R A'Hern, G Coombes, et al.
Lancet (London, England)|April 1, 2000
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialJ Y Douillard, D Cunningham, A D Roth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?A Sobrero, A Grothey, T Iveson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancerD L Clarke-Pearson, L Van Le, T Iveson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancerS Rao, D Cunningham, A de Gramont, et al.
British Journal of Cancer|August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 StudyJ W Valle, H Wasan, P Johnson, et al.
Pageof 4